– Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – – Registrational RECOVER-2 trial in schizophrenia expected to…
- Reports YCANTH® revenue, net of $4.9M for second quarter of 2024 along with the expansion of YCANTH’s distribution footprint…
MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Quantiphi, an award-winning AI-first digital engineering company today announced it has acquired a…
HALIFAX, NS / ACCESSWIRE / August 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces it will conduct full clinical…
~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~~…
Leading Victorian healthcare network integrates oncology and EHR solutions to deliver more informed care across its locations AUSTIN, Texas and VICTORIA, Australia,…
Clario integrates Mobilise-D's algorithms into Clario's Opal®️ wearable sensor system to enable real-world mobility assessments that generate accurate and reliable…
This financing is expected to support 2024 filing of New Drug Applications forNRX-100 (ketamine) and NRX-101 and to support launch…
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024…
NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. magazine revealed today that Acclinate has ranked No. 539 on its 2024…